UTI - Master Equity Unit Scheme (Mepus) · Regular · Growth
NAV
₹212.1502
as of 29 Sept 2026
Expense Ratio
—
see scheme documents
AUM
₹2,737 Cr
Lumpsum returns (CAGR)
- 1Y
- -6.48%
- 3Y
- +5.88%
- 5Y
- +5.78%
- Since Inception
- +8.81%
SIP returns (XIRR)
- 1Y
- -9.71%
- 3Y
- -0.64%
- 5Y
- +4.58%
- Since Inception
- +9.76%
Returns calculated from 20 November 2007 onwards due to a structural change in the scheme on that date. Earlier NAV history is preserved but excluded from multi-year return calculations. Periods spanning this date show —.
What history actually did — last 10 years (Sept 2016 – Sept 2026)
A ₹5,000 monthly SIP for the last 10 years (Sept 2016 – Sept 2026)
Real NAV backtest
A ₹5,000 monthly SIP would be worth ₹9,40,239 today — ₹6,00,000 invested, 8.7% XIRR.
₹6,00,000
Invested
₹9,40,239
Value today
8.7%
XIRR (p.a.)
A ₹1,00,000 lumpsum, the last 10 years (Sept 2016 – Sept 2026)
Real NAV backtest
₹1,00,000 invested 10 years ago would be ₹2,42,147 today (9.3% CAGR).
A regular withdrawal plan (SWP)
Real NAV backtest
A ₹10,00,000 corpus withdrawing ₹5,000/month since Sept 2016 would still hold ₹14,81,230.
Buying the worst day
Real NAV backtest
₹1,00,000 invested on the worst market day of the last 10 years (Sept 2016 – Sept 2026) (22 Mar 2020) would be ₹2,97,579 today (2.98×).
Historical simulation using actual published NAVs for the stated period. Past performance may or may not be sustained in the future. Not investment advice.
Risk Metrics
Trailing 1 year, annualised-0.47
Sharpe Ratio
—
Alpha
—
Beta
-0.46
Sortino
12.74%
Std Dev
-15.46%
Max Drawdown
Performance Comparison
Sectoral allocation
as of 31 Aug 2026- Banks28.32%
- IT - Software8.17%
- Retailing6.96%
- Automobiles5.94%
- Petroleum Products5.45%
- Construction4.11%
- Telecom - Services3.95%
- Finance3.53%
- Consumer Durables3.33%
- Ferrous Metals2.10%
- Insurance2.05%
- Pharmaceuticals & Biotechnology1.99%
Each sector links to the mutual funds most exposed to it.
Related reading
Thinking about UTI - Master Equity Unit Scheme (Mepus) · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Fund Details
Portfolio holdings
- 1Icici Bank Ltd9.24%
- 2Hdfc Bank Limited8.57%
- 3Reliance Industries Ltd.4.94%
- 4Kotak Mahindra Bank Ltd.4.77%
- 5Larsen & Toubro Ltd.4.11%
- 6Bharti Airtel Ltd.3.95%
- 7Eternal Limited3.46%
- 8Infosys Ltd.3.41%
- 9Bajaj Finance Ltd.3.39%
- 10Axis Bank Ltd.3.13%
What this fund does
UTI - Master Equity Unit Scheme (Mepus) · Regular · Growth by UTI Mutual Fund is a Other fund that aims to generate optimal returns for investors based on its investment mandate. The fund follows a disciplined investment process aligned with SEBI regulations for the Other category.
About This Fund
UTI - Master Equity Unit Scheme (Mepus) · Regular · Growth is a Other mutual fund offered by UTI Mutual Fund. The fund has been operational for over 20 years. It manages assets worth ₹2,737 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against BSE 100 TRI.
Who Should Invest?
- •Aggressive investors comfortable with significant short-term volatility
- •Investors with a long-term horizon of 7+ years who can ride out market cycles
- •SIP investors who can benefit from rupee cost averaging during market fluctuations